Methodological challenges in assessing the impact of comorbidities on costs in Alzheimer’s disease clinical trials

被引：0
|
作者：
Kristin Kahle-Wrobleski
Howard Fillit
Jonathan Kurlander
Catherine Reed
Mark Belger
机构：
[1] Eli Lilly and Company,
[2] Lilly Corporate Center,undefined
[3] Alzheimer’s Drug Discovery Foundation and Icahn School of Medicine at Mount Sinai,undefined
[4] Optum,undefined
[5] Eli Lilly and Company Limited,undefined
来源：
The European Journal of Health Economics | 2015年 / 16卷
关键词：
Alzheimer’s disease; Randomized controlled trials; Semagacestat; Comorbidities; Concomitant medications; Economics; I120 (health production); C900 (design of experiments);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：995 / 1004
页数：9
相关论文
共 50 条
  • [1] Methodological challenges in assessing the impact of comorbidities on costs in Alzheimer's disease clinical trials
    Kahle-Wrobleski, Kristin
    Fillit, Howard
    Kurlander, Jonathan
    Reed, Catherine
    Belger, Mark
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2015, 16 (09): : 995 - 1004
  • [2] The Impact of Disease Comorbidities in Alzheimer's Disease
    Santiago, Jose A.
    Potashkin, Judith A.
    FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
  • [3] Estimating the costs of informal care for people with Alzheimer's disease: methodological and practical challenges
    McDaid, D
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2001, 16 (04) : 400 - 405
  • [4] Medical comorbidities and ethnicity impact plasma Alzheimer's disease biomarkers: Important considerations for clinical trials and practice
    O'Bryant, Sid E.
    Petersen, Melissa
    Hall, James
    Johnson, Leigh A.
    Team, HABS-HD Study
    ALZHEIMERS & DEMENTIA, 2023, 19 (01) : 36 - 43
  • [5] Methodological challenges in pragmatic trials in Alzheimer's disease and related dementias: Opportunities for improvement
    Taljaard, Monica
    Li, Fan
    Qin, Bo
    Cui, Caroline
    Zhang, Leyi
    Nicholls, Stuart G.
    Carroll, Kelly
    Mitchell, Susan L.
    CLINICAL TRIALS, 2022, 19 (01) : 86 - 96
  • [6] Methodological Issues in Randomized Clinical Trials for Prodromal Alzheimer's and Parkinson's Disease
    de Aquino, Camila Henriques
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [7] Assessing health economic outcome in Alzheimer's disease clinical trials
    Jonsson, L.
    JOURNAL OF NUTRITION HEALTH & AGING, 2007, 11 (04): : 353 - 356
  • [8] Recruitment, retention and other methodological issues related to clinical trials for Alzheimer's disease
    Vellas, B.
    JOURNAL OF NUTRITION HEALTH & AGING, 2012, 16 (04): : 330 - 330
  • [9] Recruitment, retention and other methodological issues related to clinical trials for Alzheimer’s disease
    B. Vellas
    The journal of nutrition, health & aging, 2012, 16 : 330 - 330
  • [10] Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials
    Grill, Joshua D.
    Karlawish, Jason
    ALZHEIMERS RESEARCH & THERAPY, 2010, 2 (06)
12345